Table of contents

June 2008 Volume 4 No 6

Top

Editorial

Obesity: does a one-size intervention fit all?

Rachel Ashton

301

doi:10.1038/ncpendmet0862 | Full Text | PDF (81K)


Top

Research Highlights

Sons of women with PCOS have an increased risk of developing insulin resistance

302

doi:10.1038/ncpendmet0817 | Full Text | PDF (75K)

Artificial pancreas is feasible for pediatric patients with type 1 diabetes

302

doi:10.1038/ncpendmet0818 | Full Text | PDF (75K)

In vivo microMRI detects trabecular bone changes soon after menopause

302

doi:10.1038/ncpendmet0819 | Full Text | PDF (82K)

An autosomal-dominant GPR54 mutation implicated in central precocious puberty

303

doi:10.1038/ncpendmet0820 | Full Text | PDF (76K)

Increased glucose levels and blood pressure in IVF-conceived children

303

doi:10.1038/ncpendmet0821 | Full Text | PDF (81K)

Diabetes is associated with poor outcomes after bypass surgery

304

doi:10.1038/ncpendmet0823 | Full Text | PDF (72K)

Novel locus on chromosome 1 involved in LDL cholesterol metabolism

304

doi:10.1038/ncpendmet0824 | Full Text | PDF (72K)

MicroRNA profiling might improve the diagnostic accuracy of thyroid FNA

305

doi:10.1038/ncpendmet0822 | Full Text | PDF (70K)

Central adrenal insufficiency is common in children with Prader–Willi syndrome

305

doi:10.1038/ncpendmet0825 | Full Text | PDF (70K)

VEGF-C associated with advanced tumor stage and nodal metastases in PTC

305

doi:10.1038/ncpendmet0826 | Full Text | PDF (79K)

New predictive model for complete resolution of hypertension after adrenalectomy

306

doi:10.1038/ncpendmet0827 | Full Text | PDF (74K)

Development of hyperandrogenemia in women receiving pulsatile GnRH therapy

306

doi:10.1038/ncpendmet0828 | Full Text | PDF (80K)

Reduction in vertebral fracture risk persists after discontinuation of risedronate

307

doi:10.1038/ncpendmet0829 | Full Text | PDF (72K)

Lanreotide injections can be successfully given at home to patients with acromegaly

307

doi:10.1038/ncpendmet0830 | Full Text | PDF (72K)


Top

Practice Points

Once-yearly zoledronate—an effective preventative therapy for new fractures after hip fracture?

Ian R Reid

308

doi:10.1038/ncpendmet0813 | Full Text | PDF (102K)

Evaluation of bilateral laparoscopic adrenalectomy in adrenocorticotropic hormone-dependent Cushing's syndrome

André Lacroix

310

doi:10.1038/ncpendmet0808 | Full Text | PDF (101K)

Does primary etiology affect outcomes in adults with childhood-onset growth hormone deficiency?

Ron G Rosenfeld

312

doi:10.1038/ncpendmet0810 | Full Text | PDF (101K)

Use of plasma chromogranin A and urine fractionated metanephrines to diagnose pheochromocytoma?

Pierre-François Plouin

314

doi:10.1038/ncpendmet0812 | Full Text | PDF (103K)

Does high-trauma fracture increase the risk of subsequent osteoporotic fracture?

L Joseph Melton III

316

doi:10.1038/ncpendmet0811 | Full Text | PDF (100K)

Diabetic nephropathy—an evaluation of potential risk factors in young patients with type 1 diabetes mellitus

Francesco Chiarelli

318

doi:10.1038/ncpendmet0814 | Full Text | PDF (102K)


Top

Viewpoints

Treatment of impaired glucose tolerance in childhood

Sonia Caprio

320

Impaired glucose tolerance is a prediabetic condition that is a major risk factor for subsequent development of type 2 diabetes mellitus. As type 2 diabetes mellitus has become common among obese adolescents, options for the management of children with impaired glucose tolerance are discussed in this Viewpoint.

doi:10.1038/ncpendmet0815 | Full Text | PDF (100K)

Differentiating between body fat and lean mass—how should we measure obesity?

Abel Romero-Corral, Francisco Lopez-Jimenez, Justo Sierra-Johnson and Virend K Somers

322

Patients defined as overweight or obese on the basis of BMI have reduced mortality and cardiovascular risk when compared with their normal-weight counterparts. The authors of this Viewpoint propose that these paradoxical results might reflect how obesity is currently measured and highlight the importance of differentiating between body fat and lean mass.

doi:10.1038/ncpendmet0809 | Full Text | PDF (102K)


Top

Reviews

Continuing Medical Education

Long-term effects of pegvisomant in patients with acromegaly

Israel Hodish and Ariel Barkan

324

Achieving biochemical remission and tumor shrinkage in acromegaly can prove difficult despite a range of available therapies. Pegvisomant seems to be useful to attain the former but certain adverse effects have raised concern. This Review rounds up the evidence on the safety and efficacy of this drug, summarizes risks and benefits and suggests therapeutic approaches.

doi:10.1038/ncpendmet0831 | Full Text | PDF (188K)

Prevention of type 1 diabetes: the time has come

Jennifer Sherr, Jay Sosenko, Jay S Skyler and Kevan C Herold

334

Type 1 diabetes mellitus is a chronic process of many years, during which insulin production slowly decreases. This key feature makes the disease a potential candidate for treatment but also for prevention against symptoms becoming clinically overt. This Review discusses issues of diagnosis and risk stratification, and the development of prevention strategies.

doi:10.1038/ncpendmet0832 | Full Text | PDF (177K)

Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome

Ty Carroll, Hershel Raff and James W Findling

344

Cushing's syndrome is no longer considered rare, but making a diagnosis remains challenging. Traditional tests yield variable results. Measurement of late-night serum cortisol levels can deliver excellent sensitivity and specificity but blood samples must be taken during a hospital stay. Here, Carroll et al. put forward the case for late-night salivary cortisol measurement as a simple alternative test.

doi:10.1038/ncpendmet0837 | Full Text | PDF (159K)


Top

Case Study

A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet

Alberto Falchetti, Antonio Cilotti, Luca Vagelli, Laura Masi, Antonietta Amedei, Federica Cioppi, Francesco Tonelli and Maria Luisa Brandi

351

The patient described in this article had a history of hereditary primary hyperparathyroidism, which is usually treated surgically. When the patient developed a recurrent parathyroid adenoma she refused surgery and in this Case Study the authors describe, for the first time, the use of the calcimimetic cinacalcet in a patient with hereditary primary hyperparathyroidism.

doi:10.1038/ncpendmet0816 | Full Text | PDF (252K)


Extra navigation

.

ADVERTISEMENT